BCL2 and breast cancer: In a breast cancer study, NRP1 overexpression was found to interfere with the m6A-dependent downregulation of the Bcl-2 mRNA via WTAP and improve DNA repair ability, which in turn protects breast cancer cells from apoptosis and promotes radioresistance.